Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2024-10-30 and last amended on 2023-11-24. Previous Versions

SCHEDULE(Sections J.01.001, J.01.002 and J.01.004)

PART I

  • 1 
    The following amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues:
    • (1) 
      N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
    • (2) 
      4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
    • (3) 
      3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
    • (4) 
      2,5-dimethoxyamphetamine(2,5-dimethoxy-α-methylbenzeneethanamine)
    • (5) 
      4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
    • (6) 
      2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
    • (7) 
      N-methyl-3,4-methylenedioxyamphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
    • (8) 
      4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (9) 
      5-methoxy-3,4-methylenedioxyamphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
    • (10) 
      N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
    • (11) 
      N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
    • (12) 
      4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (13) 
      4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (14) 
      4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (15) 
      4-ethoxyamphetamine (4-ethoxy-α-methyl-benzeneethanamine)
    • (16) 
      N-Propyl-3,4-methylenedioxyamphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
    • (17) 
      N-hydroxy-3,4-methylenedioxyamphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
    • (18) 
      3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)
  • 2 
    Lysergic acid diethylamide (LSD) (N,N-diethyllysergamide) and any salt thereof
  • 3 
    N,N-Diethyltryptamine (DET) (3-[(2-diethylamino)ethyl]indole) and any salt thereof
  • 4 
    N,N-Dimethyltryptamine (DMT) (3-[(2-dimethylamino)ethyl]indole) and any salt thereof
  • 5 
    N-Methyl-3-piperidyl benzilate (LBJ) (3-[(hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof
  • 6 
    Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole) and any salt thereof
  • 7 
    Harmalol (4,9-dihydro-1-methyl-3H-pyrido(3,4-ß)indol-7-ol) and any salt thereof
  • 8 
    Psilocin (3-[2-(dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof
  • 9 
    Psilocybin (3-[2-(dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof
  • 10 
    N-(1-phenylcyclohexyl)ethylamine (PCE) and any salt thereof
  • 11 
    1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) and any salt thereof
  • 12 
    1-Phenyl-N-propylcyclohexanamine and any salt thereof
  • 13 
    Mescaline (3,4,5-trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
  • 14 
    [Repealed, SOR/2017-250, s. 2]
  • 15 
    2-Methylamino-1-phenyl-1-propanone and any salt thereof
  • 16 
    1-[1-(Phenylmethyl)cyclohexyl]piperidine and any salt thereof
  • 17 
    1-[1-(4-Methylphenyl)cyclohexyl]piperidine and any salt thereof
  • 18 
    Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
  • 19 
    Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
  • 20 
    Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers
  • 21 
    Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers
  • 22 
    Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
  • 23 
    Cathinone ((-)-α-aminopropiophenone) and its salts
  • 24 
    2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description:
    • any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including
      • (1) 
        4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
      • (2) 
        4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
      • (3) 
        4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
      • (4) 
        4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)
  • 25 
    AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers
  • 26 
    MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
    • (1) 
      Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)
    • (2) 
      Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)
    • (3) 
      Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)
    • (4) 
      Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)
    • but not including
    • (5) 
      Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
  • 27 
    W-18 (4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
  • 28 
    U-47700 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide), its salts, derivatives, isomers and analogues, and salts of derivatives, isomers and analogues, including
    • (1) 
      Bromadoline (4-bromo-N-(2-(dimethylamino)cyclohexyl)benzamide)
    • (2) 
      U-47109 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)benzamide)
    • (3) 
      U-48520 (4-chloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide)
    • (4) 
      U-50211 (N-(2-(dimethylamino)cyclohexyl)-4-hydroxy-N-methylbenzamide)
    • (5) 
      U-77891 (3,4-dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide)

PART II

  • 1 
    Salvia divinorum (S. divinorum), its preparations and derivatives, including
    • (1) 
      Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)
  • 2 
    Catha edulis Forsk, its preparations, derivatives, alkaloids and salts, including
    • (1) 
      Cathine (d-threo-2-amino-1-hydroxy-1-phenylpropane)
    • but not including
    • (2) 
      Cathinone ((-)-α-aminopropiophenone) and its salts
PART III
ItemColumn 1Column 2
SubstancePeriod
  • SOR/97-228, s. 25
  • SOR/2003-34, ss. 4, 5
  • SOR/2012-65, s. 1
  • SOR/2012-177, s. 1
  • SOR/2013-172, s. 2
  • SOR/2015-210, ss. 4 to 6
  • SOR/2016-72, s. 1
  • SOR/2016-106, s. 2
  • SOR/2016-239, s. 1
  • SOR/2017-12, ss. 3, 4
  • SOR/2017-250, s. 2
  • SOR/2017-278, s. 1
  • SOR/2018-69, s. 66
  • SOR/2018-85, s. 4
  • SOR/2019-171, s. 23
Previous Version

Table of Contents

 

Date modified: